É do Balacobaco_
É do Balacobaco! é um aplicativo que tem como objetivo fazer aumentar a socialização de pessoas acima de 50 anos através de compartilhamento de eventos e comunicação com outras pessoas além do seu ciclo comum.
É do Balacobaco_
É do Balacobaco! é um aplicativo que tem como objetivo fazer aumentar a socialização de pessoas acima de 50 anos através de compartilhamento de eventos e comunicação com outras pessoas além do seu ciclo comum.
É do Balacobaco! é um aplicativo que tem como objetivo fazer aumentar a socialização de pessoas acima de 50 anos através de compartilhamento de eventos e comunicação com outras pessoas além do seu ciclo comum.
É do Balacobaco_
Helping in the fight against COVID-19
meuDNA is a brazilian healthtech company that offers genetic testing focused on self-knowledge and health. It was founded in 2019 and is part of the Mendelics Group, a pioneer laboratory in DNA sequencing in Brazil.
Context
​The meuDNA COVID product was created during a very delicate moment of the pandemic, with the aim of preventing and reducing COVID-19 transmission by providing self-collection tests on digital platforms.
Challenge
Position myDNA as a reliable source of information and testing for COVID-19 during the pandemic, while also designing the product and service in a short timeframe to reach as many people as possible.​
Solution
Developed and launched a digital platform that empowers individuals to conveniently and safely access COVID-19 testing. The platform ensures secure result delivery and offers verified educational resources, strengthening the company’s credibility and public trust.
Process
From the outset, we brought together cross-functional teams around a shared objective. A well-defined design process was essential to enable an effective, phased, and scalable product development, structured as follows:
-
Defined business goals in collaboration with stakeholder;
-
Conducted user research to identify changes in habits, concerns, and preferences during the pandemic;
-
Used research insights to inform the design of meuDNA COVID, optimizing both digital and printed touchpoints;
-
Mapped the end-to-end user journey;
-
Defined key user tasks across purchase, sample collection, activation, test tracking, and results delivery.
This cross-functional process highlighted opportunities for improvement and streamlined team collaboration. Medium-fidelity wireframes and a navigable prototype were then developed to validate usability and functionality, ensuring a fast, safe, and user-centered testing experience.
​
The creation of the components was based on consistency, ease of use, and reproducibility, following the Design System.
 |  |  |
|---|---|---|
 |
Impact
The meuDNA COVID product was launched on schedule, reaching São Paulo within three months and contributing to the state’s COVID-19 mapping and control initiatives.​
​
Within two months of launch, distribution expanded across the Southeast through strategic pharmacy partnerships.
​
The operation currently has the capacity to perform over 110,000 tests per day, reinforcing large-scale prevention and care efforts.
​
Ongoing user feedback collection through NPS surveys and data monitoring ensures continuous improvement in performance and service quality.
For more detailed information about the project, please get in touch.